EREMFAT

This brand name is authorized in Austria, Estonia, Hong Kong, Malta

Active ingredients

The drug EREMFAT contains one active pharmaceutical ingredient (API):

1 Rifampicin UNII VJT6J7R4TR - RIFAMPIN

Rifampicin is an active bactericidial antituberculosis drug which is particularly active against the rapidly growing extracellular organisms and also has bactericidial activity intracellularly. Rifampicin inhibits DNA-dependent RNA polymerase activity in susceptible cells. Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme. Read about Rifampicin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J04AB02	Rifampicin	J Antiinfectives for systemic use → J04 Antimycobacterials → J04A Drugs for treatment of tuberculosis → J04AB Antibiotics
Discover more medicines within J04AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1125559, 1125560, 1186208, 1195534, 1430479, 1488944, 1804711
Country: HK	Department of Health Drug Office	Identifier(s): 52926, 52927, 52928, 52929
Country: MT	Medicines Authority	Identifier(s): AA729/29401